| Code | Description | Claims | Beneficiaries | Total Paid |
| S9083 |
Global fee urgent care centers |
29,996 |
29,622 |
$3.08M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,328 |
9,794 |
$948K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,101 |
10,678 |
$854K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
6,843 |
6,769 |
$468K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,987 |
4,727 |
$307K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,152 |
4,018 |
$252K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,656 |
3,550 |
$147K |
| 99051 |
|
3,047 |
2,881 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,527 |
1,482 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,440 |
695 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
231 |
216 |
$5K |
| 81003 |
|
2,990 |
2,766 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
64 |
60 |
$821.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
12 |
$88.53 |
| 99072 |
|
150 |
139 |
$35.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
24 |
24 |
$0.00 |